BHCM
AUGX

Brevan Howard Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Brevan Howard Capital Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,497
Closed -$125K – 1465
2024
Q1 		$125K Buy
+30,497
New +$136K ﹤0.01% 868

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Brevan Howard Capital Management's AUGX Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 30,497 shares — an estimated $125K sold.

Brevan Howard Capital Management first reported a position in AUGX in Q1 2024 and held it in 1 quarter. The position peaked at $125K in Q1 2024. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 30,497 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $125K.
  • Brevan Howard Capital Management first reported a position in Augmedix, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Augmedix, Inc. Common Stock position peaked at $125K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.